Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Parkinson’s Promising Therapies
29 January 2026

Parkinson’s Promising Therapies

Introduction Parkinson’s disease (PD), a neurological disorder, takes place due to the brain’s low capacity to generate required dopamine, showing symptoms such as slowness, plus non-motor problems, tremors, etc., that later lead to fatigue, depression and sleep issues. The treatment to...

Corcept’s Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy
29 January 2026

Corcept’s Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy

Introduction Corcept Therapeutics, a popular commercial-driven pharmaceutical company known for its main cortisol modulators, heals extreme oncologic, neurological, metabolic, and endocrinologic conditions. The company strongly prioritises technology, as cortisol activity is a core responsibility f...

Insilico builds a home for AI models
28 January 2026

Insilico builds a home for AI models

Introduction Insilico Medicine, a famous biotechnology company, is known for its excellence in generative AI. Since 2014, the company has boosted the drug discovery and establishment to the core with its brilliance and dedication. The evergreen AI technology introduced waves of opportunities to man...

Myllia’s Echoes of Silenced Genes: positive noise in CRISPR perturbation
28 January 2026

Myllia’s Echoes of Silenced Genes: positive noise in CRISPR perturbation

Introduction Myllia Biotechnology is a champion in merging bandwidth, CRISPR screening, and single-cell RNA sequencing. The company is popular as ‘Aelian Biotechnology’ along with its advanced genetic perturbation usage in specifically cancer and human cells. The company’s sequenc...

Lexicon’s ‘Get set go’ attitude after entering Phase 3
28 January 2026

Lexicon’s ‘Get set go’ attitude after entering Phase 3

Introduction Lexicon Pharmaceuticals entered the competition in 1995 with its excellent small molecule drugs harnessed with gene knockout technology. The main target of the company is chronic issues in oncology, neurology and cardiometabolism. Its popular products like LX9211 and INPEFA are a boon ...

BMS, along with Janux, is ready to upgrade cancer drugs
28 January 2026

BMS, along with Janux, is ready to upgrade cancer drugs

Introduction Bristol Myers Squibb (BMS), a leading biopharmaceutical company, aims to address immunology, cardiovascular, haematology, and oncology with its innovative and effective medicines, backed by a smart approach to discovering, establishing, and delivering excellence in these complex condit...

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia
27 January 2026

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia

Introduction IntraBio Inc. operates in the healthy air of Austin, Texas, with its innovative treatment development for common and rare neurodegenerative conditions. The company sharpens its smartness from Munich and the University of Oxford with its delivery of essential products to the calcium bui...

Charles River and Gazi University to offer plasmid DNA together
27 January 2026

Charles River and Gazi University to offer plasmid DNA together

Introduction Charles River Laboratories International, Inc., a well-known Contract Research Organisation (CRO), delivers fundamental services and products for government customers, academic space, biotech and pharmaceuticals to support and bolster development, manufacturing and drug discovery. The ...

Roche’s Investment to redeem the obesity treatments
27 January 2026

Roche’s Investment to redeem the obesity treatments

Introduction Roche (F. Hoffmann-La Roche) is a multinational healthcare company that is a champion in merging diagnostics and pharmaceuticals to innovate treatments in immunology, infectious diseases, CNS and oncology. The company’s personalised healthcare brings value and growth to the treat...

J&J’s eyes are on $100 billion
27 January 2026

J&J’s eyes are on $100 billion

Introduction Johnson & Johnson is a well-known company, recognised for its MedTech innovations and effective, innovative pharmaceuticals. Since 1886, the company has contributed to and advanced the journey in the vast healthcare sector with greater confidence and dedication, poised to thrive in...